RDNT Stock — RadNet, Inc.

RadNet, Inc. (RDNT)

Updated October 16, 2026.

RDNT is a Stock. Total return is 1348.4% over the past 35.6 years.

RadNet operates a network of outpatient diagnostic imaging centers across the United States, providing services including MRI, CT scans, PET imaging, mammography, ultrasound, and related procedures, while also developing AI-powered software solutions for radiology interpretation and health informatics. The company does not currently have an established distribution program. RadNet appeals to investors seeking exposure to healthcare services and medical imaging technology, though those focused on current income should look elsewhere.

RDNT performance

Price and return data through 2026-10-16.

Total return is 1348.4% over the past 35.6 years. Over the past year its total return — price change plus distributions reinvested — is -11.1%. Its deepest 1-year drawdown was 38.6%.

RDNT key facts

Asset type

Stock

Asset class

Equity

Inception date

02/27/1991

Distribution frequency

None

Last close

$68.80 (as of 2026-10-16)

Market cap

$5,414,405,682

Average volume

385875.0

Beta

1.411

Payout ratio

0.0%

Forward P/E

36.63

EPS

$-0.27

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

RDNT risks and drawbacks

The deepest 1-year drawdown on record here is 38.6%.

Who may consider RDNT — and who may not

It is a weaker fit for investors who need monthly cash flow (RDNT does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on RDNT

• All tickers starting with R

Tagged: Healthcare.

Frequently asked questions